Equity Overview
Price & Market Data
Price: $9.95
Daily Change: +$0.24 / 2.41%
Daily Range: $9.94 - $9.98
Market Cap: $172,221,072
Daily Volume: 4,719
Performance Metrics
1 Week: 12.91%
1 Month: 21.22%
3 Months: 24.01%
6 Months: -34.52%
1 Year: 86.37%
YTD: 19.29%
Company Details
Employees: 36
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.